MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Probing the Parieto-Premotor Network in Writer’s Cramp Using Transcranial Magnetic Stimulation

    J. Park, P. Mathew, J. Sackett, T. Wu, M. Villegas, M. Hallett (Goyang, Republic of Korea)

    Objective: We aimed to probe the parieto-premotor network using transcranial magnetic stimulation (TMS), and further investigate its influence on the motor cortex in patients with…
  • MDS Virtual Congress 2020

    Parkinson’s Disease in Israel – Initial Symptoms and Comorbidities from 20 years of Follow Up in a Population-based Cohort

    Y. Barer, N. Gavrielov, P. Coloma, M. Martinec, I. Korolev, I. Goldshtein (Tel Aviv, Israel)

    Objective: To describe the epidemiology of Parkinson’s disease (PD) in Israel during a 20-year period, 2000–2019, and to characterize initial symptoms and comorbidities of PD…
  • MDS Virtual Congress 2020

    Application of a Simple Parkinson’s Disease Risk Score in a Longitudinal Population Based Cohort

    K. Marini, P. Mahlknecht, F. Tutzer, H. Stockner, A. Gasperi, A. Djamshidian-Tehrani, P. Willeit, S. Kiechl, J. Willeit, G. Rungger, A.J Noyce, A. Schrag, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To apply the PREDICT-PD algorithm of risk indicators for Parkinson’s disease (PD), in a prospective community-based study (the Bruneck Study), representative of the general…
  • MDS Virtual Congress 2020

    Sulpiride-induced Parkinsonism in Peptic Ulcer and Gastroesophageal Reflux Disease Patients: A Nationwide Population-Based Study

    C.Y Wei, M.C Lin, W.M Kung (Changhua County, Taiwan)

    Objective: This study aimed to investigate the risk factors and the cumulative daily dose associated with sulpiride-induced parkinsonism (SIP) in peptic ulcer disease (PUD) and…
  • MDS Virtual Congress 2020

    Movement Disorders in Spanish Cathedrals

    P.J Garcia-Ruiz, J.C Martinez Castrillo, L. Diaz Feliz (Madrid, Spain)

    Objective: To review Movement Disorders represented in some Spanish Cathedrals. Background: Movement Disorders have a recent history in medicine but it is possible to find…
  • MDS Virtual Congress 2020

    Deutetrabenazine for Huntington’s disease chorea—A Single Center’s Experience

    D. Fischer, R. Caskey, M. Dean, V. Sung (Birmingham, AL, USA)

    Objective: To evaluate real-world use and outcomes with deutetrabenazine for Huntington’s disease. Background: Grade A evidence for Huntington’s disease chorea treatment includes tetrabenazine and deutetrabenazine.…
  • MDS Virtual Congress 2020

    How Well Does the Composite Unified Huntington’s Disease Rating Scale (cUHDRS) Reflect Disease Progression in Huntington’s disease (HD)?

    C. Snell, H. Smith, J. Castleton, A. Hall, A. Smirnova, B. Wright, P. Gilbert, J. Corey-Bloom (La Jolla, CA, USA)

    Objective: To examine the usefulness of the cUHDRS in reflecting disease progression in a well-characterized group of mild to moderate HD subjects followed at one…
  • MDS Virtual Congress 2020

    Striatal neurodegeneration in the presymptomatic phase of X-linked Dystonia-Parkinsonism

    H. Hanssen, M. Heldmann, J. Dy, J. Tantianpact, J. Steinhardt, A. Sprenger, A. Domingo, C. Reyes, R. Rosales, C. Klein, T. Münte, A. Westenberger, J. Oropilla, C. Diesta, N. Brüggemann (Luebeck, Germany)

    Objective: To identify structural brain changes in patients with X-linked dystonia-parkinsonism (XDP) and non-manifesting carriers of the TAF1 SVA retrotransposon insertion (NMC). Background: XDP is…
  • MDS Virtual Congress 2020

    4-Chlorokynurenine inhibits L-Dopa-induced dyskinesias in non-human parkinsonian primates

    T. Di Paolo, M. Bourque, R. Snodgrass (Quebec City, QC, Canada)

    Objective: This study investigated the antidyskinetic activity of 4-chlorokynurenine (AV-101) in parkinsonian monkeys with L-Dopa-induced dyskinesias. Background: The common treatment for Parkinson’s disease (PD) is L-Dopa…
  • MDS Virtual Congress 2020

    Frontal Cavernous angioma manifested as acquired dystonic tremor: Two case reports

    D. Chaity (Dublin, Ireland)

    Objective: To highlight unilateral slow dystonic tremor as an uncommon presentation of frontal cavernoma. Background: Acquired dystonia, results from injury to the brain, poisoning or…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley